Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
266.72B | 123.93B | 54.95B | 45.54B | 24.92B | 26.52B | Gross Profit |
44.30B | 20.42B | 8.12B | 7.65B | 4.89B | 6.02B | EBIT |
8.58B | 6.89B | 2.96B | 3.07B | 864.77M | 1.32B | EBITDA |
11.74B | 8.46B | 4.09B | 4.10B | 1.77B | 1.87B | Net Income Common Stockholders |
1.16B | 2.85B | 2.32B | 2.54B | 953.49M | 713.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
9.51B | 16.23B | 9.51B | 7.34B | 5.28B | 4.18B | Total Assets |
151.12B | 137.58B | 51.20B | 42.01B | 30.69B | 23.85B | Total Debt |
110.83B | 99.25B | 30.00B | 22.96B | 16.14B | 12.49B | Net Debt |
101.32B | 83.02B | 20.49B | 15.62B | 10.86B | 8.31B | Total Liabilities |
123.35B | 114.45B | 33.92B | 27.36B | 19.07B | 14.49B | Stockholders Equity |
26.14B | 19.56B | 16.87B | 14.65B | 11.62B | 9.36B |
Cash Flow | Free Cash Flow | ||||
0.00 | 1.23B | -3.82B | -2.40B | -1.92B | -1.14B | Operating Cash Flow |
0.00 | 2.29B | -3.52B | -2.19B | -1.50B | -705.54M | Investing Cash Flow |
0.00 | -6.36B | -840.00M | -1.76B | -121.31M | -1.71B | Financing Cash Flow |
0.00 | 10.87B | 7.04B | 5.48B | 2.62B | 1.67B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | ¥18.31B | 11.95 | 2.58% | 36.19% | ― | ||
76 Outperform | ¥9.21B | 11.72 | 2.79% | 11.34% | 22.75% | ||
72 Outperform | ¥28.42B | 7.13 | 5.02% | -4.95% | -39.29% | ||
71 Outperform | ¥10.03B | 5.76 | 4.45% | 64.86% | 74.45% | ||
67 Neutral | ¥5.10B | 5.53 | 4.08% | 10.95% | -24.17% | ||
62 Neutral | $6.91B | 11.20 | 2.93% | 3.90% | 2.68% | -25.01% | |
58 Neutral | ¥23.14B | 14.70 | 5.31% | 116.91% | -107.34% |